Hancock Health Partners with Arrive AI to Launch Autonomous Medical Delivery System
Hancock Regional Hospital has launched a two-year partnership with Arrive AI to implement robotic delivery systems for medical specimens, aiming to reduce costs, improve efficiency, and accelerate critical test results.
Hancock Health and Arrive AI have initiated a two-year partnership to deploy autonomous robotic delivery systems at Hancock Regional Hospital in Greenfield, Indiana. This collaboration represents Arrive AI's first revenue-generating deployment and focuses on exploring the potential of asynchronous robotic automation for medical deliveries within healthcare facilities.
The program began operations with the installation of Arrive AI's patented Arrive Point, a secure autonomous delivery station that serves as a chain-of-custody-compliant hub for biospecimen transport from the hospital's cancer center. This technology aims to address operational inefficiencies identified by Hancock Health, where medical personnel currently make more than a dozen daily trips between clinics and the hospital lab to deliver specimens, pulling staff from critical duties and delaying lab results while increasing labor costs.
Steve Long, President and CEO of Hancock Health, emphasized that embracing automation opens the door to transformative improvements in healthcare delivery. "Reducing costs, accelerating the delivery of critical items like test results, medications, and lab specimens, and strengthening the security and reliability of our services enhances the overall patient experience," Long stated.
The partnership positions Hancock Health at the forefront of autonomous medical logistics, with potential applications across its broader network of more than 30 locations in East Central Indiana. Dan O'Toole, CEO of Arrive AI, described the deployment as a significant milestone, moving from pilot programs to generating revenue and demonstrating real-world value of autonomous delivery solutions.
The phased rollout includes a comprehensive readiness evaluation, installation of robotic technology at the Sue Ann Wortman Cancer Center and laboratory, development of optimized delivery routes, expansion to off-campus locations, and the introduction of drone-based transport for time-sensitive medical deliveries. Each phase will incorporate the Arrive Point technology, providing standardized and secure interfaces for all chain-of-custody transfers.
According to the agreement terms, Arrive AI anticipates leveraging insights from this trial by September 2027 to develop a scalable framework integrating ground robotics, courier networks, and drones across Hancock Health's entire network. The company will spearhead design, deployment, and optimization of this integrated system, ensuring regulatory compliance, operational feasibility, and validated return on investment. Key efficiency strategies include replacing manual specimen transport with robotic automation, providing Arrive Point storage devices for 24/7 deliveries, and deploying drones for urgent and off-campus transport needs. Learn more details about the company's patents at https://arriveai.com/patents and see videos of the smart mailbox in action at https://arriveai.com/videos.